• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非糖尿病性内分泌疾病中的非酒精性脂肪性肝炎

NASH in Nondiabetic Endocrine Disorders.

作者信息

Wang Timothy, Yang Wei, Karakas Sidika, Sarkar Souvik

机构信息

1 Department of Internal Medicine, University of California , Davis, Sacramento, California.

2 Division of Endocrinology, University of California , Davis, Sacramento, California.

出版信息

Metab Syndr Relat Disord. 2018 Sep;16(7):315-320. doi: 10.1089/met.2018.0044. Epub 2018 Jun 6.

DOI:10.1089/met.2018.0044
PMID:29873585
Abstract

Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of disease, including hepatic steatosis, inflammation, and fibrosis. NAFLD carries the risk of progression to cirrhosis with its associated complications and hepatocellular carcinoma. It is now the most common liver disease in the Western world and its prevalence is increasing. While the association between NAFLD and type 2 diabetes has been well documented, there is significantly less understanding of the pathophysiology and progression of NAFLD in patients with other endocrine disorders affecting metabolism in various ways. Some of the more common endocrine disorders such as polycystic ovarian syndrome, growth hormone deficiency, hypothyroidism, and hypogonadism are known in clinical practice to be associated with NAFLD. Medications that alter the endocrine system such as tamoxifen and adrenal steroids have also been attributed to significant NAFLD. The key to management of NAFLD at this time are dietary changes and exercise to achieve weight loss. Unfortunately, a large proportion of the patients with these endocrine disorders are unable to achieve either. This review aims to examine and summarize the current published literature that have evaluated the association between NAFLD and the above endocrine disorders and potential therapeutic interventions in each case.

摘要

非酒精性脂肪性肝病(NAFLD)涵盖一系列疾病,包括肝脂肪变性、炎症和纤维化。NAFLD有进展为肝硬化及其相关并发症和肝细胞癌的风险。它现已成为西方世界最常见的肝脏疾病,且患病率正在上升。虽然NAFLD与2型糖尿病之间的关联已有充分记录,但对于以各种方式影响代谢的其他内分泌疾病患者中NAFLD的病理生理学和进展的了解却少得多。临床实践中已知一些较常见的内分泌疾病,如多囊卵巢综合征、生长激素缺乏症、甲状腺功能减退症和性腺功能减退症与NAFLD有关。改变内分泌系统的药物,如他莫昔芬和肾上腺类固醇,也被认为与严重的NAFLD有关。目前NAFLD管理的关键是通过饮食改变和运动来实现体重减轻。不幸的是,这些内分泌疾病的很大一部分患者无法做到这两点。本综述旨在检查和总结当前已发表的文献,这些文献评估了NAFLD与上述内分泌疾病之间的关联以及每种情况下的潜在治疗干预措施。

相似文献

1
NASH in Nondiabetic Endocrine Disorders.非糖尿病性内分泌疾病中的非酒精性脂肪性肝炎
Metab Syndr Relat Disord. 2018 Sep;16(7):315-320. doi: 10.1089/met.2018.0044. Epub 2018 Jun 6.
2
Endocrine causes of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的内分泌病因
World J Gastroenterol. 2015 Oct 21;21(39):11053-76. doi: 10.3748/wjg.v21.i39.11053.
3
NAFLD in Some Common Endocrine Diseases: Prevalence, Pathophysiology, and Principles of Diagnosis and Management.某些常见内分泌疾病中的非酒精性脂肪性肝病:患病率、病理生理学以及诊断和治疗原则。
Int J Mol Sci. 2019 Jun 11;20(11):2841. doi: 10.3390/ijms20112841.
4
Non-alcoholic fatty liver disease across endocrinopathies: Interaction with sex hormones.非酒精性脂肪性肝病与内分泌疾病:与性激素的相互作用。
Front Endocrinol (Lausanne). 2022 Nov 7;13:1032361. doi: 10.3389/fendo.2022.1032361. eCollection 2022.
5
Pathophysiology of NASH in endocrine diseases.内分泌疾病中NASH的病理生理学
Endocr Connect. 2021 Feb;10(2):R52-R65. doi: 10.1530/EC-20-0490.
6
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
7
Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.多囊卵巢综合征女性非酒精性脂肪性肝病综述。
World J Gastroenterol. 2014 Oct 21;20(39):14172-84. doi: 10.3748/wjg.v20.i39.14172.
8
Nonalcoholic fatty liver disease in children and adolescents - Relationship with Polycystic Ovary Syndrome.儿童和青少年非酒精性脂肪性肝病——与多囊卵巢综合征的关系
Curr Pharm Des. 2015;21(35):5144-50. doi: 10.2174/1381612821666150928105959.
9
Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的组织病理学
World J Gastroenterol. 2014 Nov 14;20(42):15539-48. doi: 10.3748/wjg.v20.i42.15539.
10
Diagnosis and management of secondary causes of steatohepatitis.脂肪性肝炎的继发原因的诊断与治疗。
J Hepatol. 2021 Jun;74(6):1455-1471. doi: 10.1016/j.jhep.2021.01.045. Epub 2021 Feb 10.

引用本文的文献

1
The Unexpected Detection of Esophageal Varices Caused by Liver Cirrhosis in a 47-Year-Old Man Treated with a Growth Hormone in Childhood.一名47岁男性儿童期接受过生长激素治疗,现意外检测出肝硬化所致食管静脉曲张。
Diseases. 2024 Oct 12;12(10):251. doi: 10.3390/diseases12100251.
2
Low-Normal Thyroid Function Is Not Associated with Either Non-Alcoholic Fatty Liver Disease or with Metabolic Dysfunction-Associated Fatty Liver Disease.甲状腺功能略低于正常水平与非酒精性脂肪性肝病或代谢功能障碍相关脂肪性肝病均无关联。
Life (Basel). 2023 Apr 19;13(4):1048. doi: 10.3390/life13041048.
3
Therapeutic pipeline in nonalcoholic steatohepatitis.
非酒精性脂肪性肝炎的治疗药物研发管线。
Nat Rev Gastroenterol Hepatol. 2021 Jun;18(6):373-392. doi: 10.1038/s41575-020-00408-y. Epub 2021 Feb 10.
4
Pathophysiology of NASH in endocrine diseases.内分泌疾病中NASH的病理生理学
Endocr Connect. 2021 Feb;10(2):R52-R65. doi: 10.1530/EC-20-0490.
5
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.甲状腺功能减退症引起的非酒精性脂肪性肝病(HIN):发病机制与新兴治疗选择。
Int J Mol Sci. 2020 Aug 18;21(16):5927. doi: 10.3390/ijms21165927.